Australian Clinical Labs (ASX:ACL) hikes profit & revenue expectations

Latest Company News - Finance News Network

English - December 20, 2021 23:57 - 1000 KB
Business News News Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Stocks of the Hour: AMP, Magellan Financial, Australian Clinical Labs

Next Episode: Nine (ASX:NEC) inks $650m broadcast deal

21 Dec 2021 - Australian Clinical Labs (ASX:ACL) has upgraded its earnings and revenue forecast for the first half of FY22, underpinned by strong demand for Covid-19 testing.